Our Scans · Medical Devices · Weekly Summary

• [New] Midjourney said that it's planning to open its first ultrasound scanner spa at the end of 2027, but it has another hurdle to jump: FDA approval. theregister
• [New] A San Francisco startup best known for its AI-generation software is making a bizarre leap into medical imaging, and trying to says it hopes draw curiosity-seekers into its new spa to get scanned. theregister
• [New] In the Phase 3 TALAPRO-2 trial, talazoparib combined with enzalutamide reduced the risk of disease progression or death by 55% in patients with HRR-deficient metastatic castration-resistant prostate cancer, leading to FDA approval. Persistence Market Research
• [New] As regulatory frameworks mature and awareness of AI's clinical value increases, South America is expected to witness steady expansion in AI-powered medical imaging applications across radiology, oncology, and cardiology. Precedence Research
• [New] The first FDA approvals of fully AI-discovered drugs are expected in the coming years, pending successful clinical trials. Deepgram
• Platforms like Medifakt (a decentralized blockchain for medical imaging and data sharing) and earlier pilots (e.g., Blockpharma concepts and DHL collaborations) create verifiable provenance from manufacturer to pharmacy, drastically reducing fake drugs that endanger lives. SISGAIN
• Tempus platform uses AI to match patients with appropriate clinical trials for preventive interventions, analyzing genetic data and medical history to identify individuals who might benefit from experimental therapies or prevention strategies. WTT Solutions
• In 2026, AI will be embedded across the value chain, from R&D to clinical trials to operations, reshaping the way companies get work done. Clarkston Consulting
• The use of artificial intelligence in drug R&D will allow for quicker identification of targets, selection of candidates, and design of clinical trials. tradingkey.com
• Because of the battery of tests needed before a new vaccine can be given to humans, getting clinical trials under way will probably take many months. Insurance Journal
• Lilly has submitted for FDA approval for obesity, with a T2D submission expected later in 2026. SNAQ
• In the surgery business, J&J plans to be a player in robotic surgery and filed for FDA approval of its soft tissue robot called OTTAVA. Yahoo Finance
• First clinical trials using compact editors could begin within the next 2-3 years. GeneEditing101
• Lilly is jockeying for FDA approval of its own oral obesity candidate, orforglipron, which could come quickly on the heels of Novo's nod. / USA Fierce Pharma
• Clinical trials are underway for various conditions, including sickle cell anaemia and cystic fibrosis, and we anticipate seeing the first wave of approved gene therapies within the next few years. Innovation Hub Live
• Australian biotech company HaemaLogiX is reportedly looking to float on the ASX sometime soon which will help fund the next phase of its immunotherapy pipeline by expanding its manufacturing capabilities and accelerating clinical trials. IG
• Hong Kong and Shenzhen will establish a Greater Bay Area Clinical Trial Collaboration Platform to extend R&D networks and accelerate clinical trials. ChoZan
• Novo Nordisk secured the long-awaited FDA approval for its oral Wegovy pill to treat obesity and reduce cardiovascular risk in late December, followed by its commercial launch in early January. Yahoo Finance
• By 2026, we can expect to see custom prosthetics and implants manufactured using patient-specific data and biocompatible materials. Forgely
• The Growing Specialty Drug Tsunami Specialty medication use will keep growing, particularly as GLP-1 drugs gain FDA approval for more than diabetes and obesity. DrFirst.com

Last updated: 24 June 2026